TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36113535

Group type: EXPERIMENTAL
Intervention: Antenatal dexamethasone
Number of subjects: 2828

Group type: COMPARATOR
Intervention: No intervention (placebo)
Number of subjects: 2828
Study: 33214014

Group type: EXPERIMENTAL
Intervention: Patellar Denervation (PD)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Non-Patellar Denervation (non-PD)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Both groups (PD and non-PD)
Number of subjects: 241
Study: 33438732

Group type: EXPERIMENTAL
Intervention: M-system (endoscopic diagnostic process system)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (patients with early differentiated carcinoma, undifferentiated carcinoma or inflammation)
Number of subjects: 16
Study: 32485166

Group type: EXPERIMENTAL
Intervention: Aquatic habitats with bare soil
Number of subjects: 5123

Group type: EXPERIMENTAL
Intervention: Aquatic habitats with culicine larvae
Number of subjects: 5123

Group type: EXPERIMENTAL
Intervention: Highly turbid habitats
Number of subjects: 5123

Group type: EXPERIMENTAL
Intervention: Presence of predators in aquatic habitats
Number of subjects: 5123
Study: 32873260

Group type: EXPERIMENTAL
Intervention: iPA (intervention targeting physical activity)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: iSED (intervention targeting sedentary behaviour)
Number of subjects: 263
Study: 34290173

Group type: EXPERIMENTAL
Intervention: Triamcinolone 40 mg
Number of subjects: 78

Group type: COMPARATOR
Intervention: Verapamil 2.5 mg
Number of subjects: 78
Study: 36289300

Group type: EXPERIMENTAL
Intervention: Psychobiotic diet (high in prebiotic and fermented foods)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Psychobiotic diet
Number of subjects: 45
Study: 34207080

Group type: EXPERIMENTAL
Intervention: Diacutaneous Fibrolysis
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study: 35285439

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 94

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 94
Study: 32729065

Group type: EXPERIMENTAL
Intervention: Interventional group (IPI monitor)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (observational)
Number of subjects: 80
Study: 32566130

Group type: EXPERIMENTAL
Intervention: Babble Boot Camp (BBC) intervention
Number of subjects: 5

Group type: COMPARATOR
Intervention: Conventional management (control)
Number of subjects: 5
Study: 36441257

Group type: EXPERIMENTAL
Intervention: XGBoost model
Number of subjects: 2469

Group type: EXPERIMENTAL
Intervention: Logistic Regression model
Number of subjects: 2469

Group type: EXPERIMENTAL
Intervention: Support Vector Machine model
Number of subjects: 2469
Study: 35776928

Group type: EXPERIMENTAL
Intervention: Parallel insertion of buddy anchor; 16.1 ± 1.8 cN·m insertion torque
Number of subjects: 24

Group type: COMPARATOR
Intervention: Divergent insertion of buddy anchor; 12.0 ± 1.5 cN·m insertion torque
Number of subjects: 24
Study: 32066534

Group type: EXPERIMENTAL
Intervention: Xpert MTB/RIF Ultra (Ultra)
Number of subjects: 1133

Group type: COMPARATOR
Intervention: Xpert MTB/RIF (Xpert)
Number of subjects: 1133
Study: 35060026

Group type: EXPERIMENTAL
Intervention: Enhanced coagulation-flocculant process incorporating magnetic powder; 28.42 mg/L coagulant, 623 mg/L magnetic powder, 0.18 mg/L flocculant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single RSM model
Number of subjects: 0

Group type: COMPARATOR
Intervention: RSM-ANN model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treated water
Number of subjects: 0
Study: 33289602

Group type: EXPERIMENTAL
Intervention: Sodium Hyaluronate/Chondroitin Sulfate Preservative-free Ophthalmic Solution (SH/CS‐PF)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Systane® Ultra (PEG/PG)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Systane® Ultra PF (PEG/PG‐PF)
Number of subjects: 326
Study: 35365187

Group type: EXPERIMENTAL
Intervention: Huzhang granules (HZG)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study: 36199177

Group type: EXPERIMENTAL
Intervention: Fenugreek seed extract (5 cc) for 4 months
Number of subjects: 82
Study: 32634642

Group type: EXPERIMENTAL
Intervention: dexmedetomidine + remifentanil
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: dexmedetomidine + ½ remifentanil
Number of subjects: 75

Group type: COMPARATOR
Intervention: remifentanil alone
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 75
Study: 35793878

Group type: EXPERIMENTAL
Intervention: Lateral needling at CV 23, once a day for 5 days a week, for 4 courses (total duration not specified).
Number of subjects: 64

Group type: COMPARATOR
Intervention: Swallowing rehabilitation training, once a day for 5 days a week, for 4 courses (total duration not specified).
Number of subjects: 64
Study: 34116144

Group type: EXPERIMENTAL
Intervention: Sacituzumab govitecan (SG) 10 mg/kg intravenously on days 1 and 8, every 21 days
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: Sacituzumab govitecan (SG)
Number of subjects: 468

Group type: COMPARATOR
Intervention: Chemotherapy treatment of physician's choice (TPC)
Number of subjects: 468
Study: 33136751

Group type: EXPERIMENTAL
Intervention: Long-acting (LA) regimen of cabotegravir (CAB) and rilpivirine (RPV)
Number of subjects: 591

Group type: COMPARATOR
Intervention: Current antiretroviral regimen (CAR)
Number of subjects: 591
Study: 35108307

Group type: EXPERIMENTAL
Intervention: Testing available
Number of subjects: 1194

Group type: EXPERIMENTAL
Intervention: Positive test result
Number of subjects: 1194

Group type: COMPARATOR
Intervention: No testing available
Number of subjects: 1194
Study: 32652899

Group type: EXPERIMENTAL
Intervention: Serum myostatin expression in T1D patients
Number of subjects: 55

Group type: COMPARATOR
Intervention: Serum myostatin expression in controls
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Lean mass correlation
Number of subjects: 55

Group type: COMPARATOR
Intervention: Maximal voluntary contraction (MVC) correlation
Number of subjects: 55

Group type: COMPARATOR
Intervention: Body fat mass correlation
Number of subjects: 55
Study: 36372355

Group type: EXPERIMENTAL
Intervention: Isatuximab plus Carfilzomib and Dexamethasone (Isa-Kd)
Number of subjects: 302
Study: 33140886

Group type: EXPERIMENTAL
Intervention: Opioid receptor antagonist naltrexone
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (inert substance)
Number of subjects: 42
Study: 35441795

Group type: EXPERIMENTAL
Intervention: Tumescent solution with ropivacaine
Number of subjects: 314

Group type: COMPARATOR
Intervention: Tumescent solution without ropivacaine
Number of subjects: 314

Group type: COMPARATOR
Intervention: Tumescent solution with/without ropivacaine (inter-group comparison)
Number of subjects: 314
Study: 33780271

Group type: EXPERIMENTAL
Intervention: 6-session solution-oriented goal-setting program
Number of subjects: 52

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 52
Study: 32690072

Group type: EXPERIMENTAL
Intervention: Olanzapine (starting dose 5 mg daily, maximum 20 mg daily)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 58
Study: 35606099

Group type: EXPERIMENTAL
Intervention: Supervised exercise intervention
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity group intervention
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 34302571

Group type: EXPERIMENTAL
Intervention: Inoculation with Azospirillum brasilense
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control (no inoculation with A. brasilense)
Number of subjects: 4
Study: 35068328

Group type: COMPARATOR
Intervention: Abdominopelvic exercise program (AEP)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Abdominopelvic exercise program with postural instructions (AEPPI)
Number of subjects: 47
Study: 33545781

Group type: EXPERIMENTAL
Intervention: Comfort care based on the collaborative care model (CCM)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 104
Study: 32708743

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation including prebiotics and probiotics for four weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 35238494

Group type: EXPERIMENTAL
Intervention: BoNT + KinesioTaping
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: BoNT + ShamTaping
Number of subjects: 25

Group type: COMPARATOR
Intervention: BoNT
Number of subjects: 25
Study: 32583707

Group type: EXPERIMENTAL
Intervention: Yoga intervention (triweekly for 12 weeks)
Number of subjects: 22
Study: 33588590

Group type: EXPERIMENTAL
Intervention: Intravenous Thrombolysis (IVT)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 33105360

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) in multijoint to single-joint order (MJ-SJ)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) in single-joint to multijoint order (SJ-MJ)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Nonexercise control group (CON)
Number of subjects: 44
Study: 36163903

Group type: EXPERIMENTAL
Intervention: Ponatinib 45 mg QD (PACE)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Ponatinib 45 mg QD (OPTIC)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Ponatinib (PACE)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Ponatinib (OPTIC)
Number of subjects: 364
Study: 33999133

Group type: EXPERIMENTAL
Intervention: This is Quitting, a fully automated text message program for vaping cessation that delivers social support and cognitive and behavioral coping skills training.
Number of subjects: 2588

Group type: COMPARATOR
Intervention: Assessment-only control (no additional intervention).
Number of subjects: 2588

Group type: EXPERIMENTAL
Intervention: This is Quitting intervention.
Number of subjects: 2588
Study: 35078532

Group type: EXPERIMENTAL
Intervention: Hearing dogs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 0
Study: 34521461

Group type: EXPERIMENTAL
Intervention: hUCB‐MSCs (1.0 × 10^7 cells/2 mL)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: hUCB‐MSCs (3.0 × 10^7 cells/2 mL)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: hUCB‐MSCs (1.0 × 10^7 cells/2 mL) and (3.0 × 10^7 cells/2 mL)
Number of subjects: 9
Study: 34516051

Group type: EXPERIMENTAL
Intervention: Teledentistry (education via Telegram application)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional education (in-person education)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (Teledentistry and Conventional education)
Number of subjects: 60
Study: 33022321

Group type: EXPERIMENTAL
Intervention: GP-endorsed reminder letter
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Standard reminder letter
Number of subjects: 1200
Study: 35687604

Group type: EXPERIMENTAL
Intervention: Repeated Agility (RA)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Repeated Change-of-Direction (RCOD)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fatigue development in RA
Number of subjects: 14

Group type: COMPARATOR
Intervention: Fatigue development in RCOD
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ratings of perceived exertion (RPE) for RA
Number of subjects: 14

Group type: COMPARATOR
Intervention: Ratings of perceived exertion (RPE) for RCOD
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Total RA times
Number of subjects: 14
Study: 32524584

Group type: EXPERIMENTAL
Intervention: Early relapse after high-dose melphalan autologous stem cell transplant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Later relapsing patients after high-dose melphalan autologous stem cell transplant
Number of subjects: 0
Study: 32808239

Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 443

Group type: COMPARATOR
Intervention: Gemcitabine
Number of subjects: 443

Group type: COMPARATOR
Intervention: Capecitabine
Number of subjects: 443
Study: 36456007

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided puncture
Number of subjects: 542

Group type: COMPARATOR
Intervention: Fluoroscopy-guided puncture
Number of subjects: 542
Study: 33380392

Group type: EXPERIMENTAL
Intervention: Thoracic paravertebral block analgesia (TA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Epidural analgesia (EA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intravenous analgesia (GA)
Number of subjects: 90
Study: 36381163

Group type: EXPERIMENTAL
Intervention: Combined bladder neck and supramontanal sparing TURP (Group 2)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional TURP (Group 1)
Number of subjects: 90
Study: 32473675

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33668309

Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 33032661

Group type: EXPERIMENTAL
Intervention: Targeted indoor residual spraying (TIRS) applied 1-2 months prior to the ABV season
Number of subjects: 4600
Study: 33274466

Group type: EXPERIMENTAL
Intervention: MLT‐treated cryopreservation (10−9 M)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No‐MLT‐treated cryopreservation (NC)
Number of subjects: 0
Study: 33148333

Group type: EXPERIMENTAL
Intervention: Theta frequency EA (6 Hz)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Gamma frequency EA (40 Hz)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sham EA (no current)
Number of subjects: 66
Study: 33858190

Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin plus standard chemotherapy (GO + SC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard chemotherapy alone (SC)
Number of subjects: 0
Study: 35635622

Group type: COMPARATOR
Intervention: Telemedicine consultation (TEL)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Face-to-face consultation (FTF)
Number of subjects: 271
Study: 33786671

Group type: EXPERIMENTAL
Intervention: Cetrimide 2% followed by methylene blue dye and aPDT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Experimental solution (methylene blue dye with cetrimide) and aPDT
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chlorhexidine 2%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cetrimide 2%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: aPDT alone
Number of subjects: 60
Study: 32872501

Group type: EXPERIMENTAL
Intervention: Best Practice School Lunches (BPSL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Typical School Lunches (TSL)
Number of subjects: 40
Study: 35171918

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 63

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 63
Study: 34628241

Group type: EXPERIMENTAL
Intervention: Urox® (Bedtime Buddy®)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 34843657

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Aerobic exercise and caloric restriction
Number of subjects: 99

Group type: COMPARATOR
Intervention: Usual activity
Number of subjects: 99
Study: 33327963

Group type: EXPERIMENTAL
Intervention: Mixed Reality guidance system using Microsoft HoloLens
Number of subjects: 164

Group type: COMPARATOR
Intervention: Instructor-led instructions
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Self-evaluation
Number of subjects: 164

Group type: COMPARATOR
Intervention: Quality of instructions (Control group)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: MR system usability (SUS score)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: NASA task load index (MR group)
Number of subjects: 164
Study: 34939916

Group type: EXPERIMENTAL
Intervention: Complex intervention involving spiritual history taking by primary care physicians and advice on home remedies and regional programs for the elderly.
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Complex intervention for patients using home remedies before the trial.
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Complex intervention for patients who stated that spirituality played a major role in their lives.
Number of subjects: 297
Study: 33712909

Group type: EXPERIMENTAL
Intervention: Balneological outpatient treatment (hydrotherapy and peloidotherapy)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Home exercise (Control)
Number of subjects: 74
Study: 33116410

Group type: EXPERIMENTAL
Intervention: Test formulation of valsartan 80 mg capsules under fasting conditions
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Test formulation of valsartan 80 mg capsules under fed conditions
Number of subjects: 78

Group type: COMPARATOR
Intervention: Reference formulation of valsartan 80 mg capsules
Number of subjects: 78
Study: 36165675

Group type: EXPERIMENTAL
Intervention: 5 mg/day prednisolone for 2 years
Number of subjects: 451

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 451
Study: 34488719

Group type: EXPERIMENTAL
Intervention: Practice facilitation intervention addressing interpreter engagement
Number of subjects: 55
Study: 32386065

Group type: EXPERIMENTAL
Intervention: Brand bupropion XL 300 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Generic bupropion XL 300 mg
Number of subjects: 0
Study: 37164774

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (ICT) followed by curative chemo-radiotherapy (CTRT) or surgery and adjuvant (chemo)RT
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (ICT)
Number of subjects: 35
Study: 33420736

Group type: EXPERIMENTAL
Intervention: Video group (VG)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 378
Study: 32690330

Group type: COMPARATOR
Intervention: Monitoring recovery (Group A, n = 97)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Monitoring recovery + mutual aid association (Group B, n = 112)
Number of subjects: 207
Study: 33324987

Group type: EXPERIMENTAL
Intervention: ADHD
Number of subjects: 0
Study: 32029248

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 1660

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 1660

Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 1660
Study: 33949052

Group type: EXPERIMENTAL
Intervention: kcal labelling (standard labelling plus drink kilocalorie information)
Number of subjects: 1084

Group type: EXPERIMENTAL
Intervention: kcal + PACE labelling (standard labelling and kilocalorie information, plus information on physical activity needed to compensate for drink calories)
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Control (standard alcohol labelling)
Number of subjects: 1084
Study: 33620447

Group type: EXPERIMENTAL
Intervention: Internet-based treatment via smartphone application
Number of subjects: 105
Study: 34780107

Group type: EXPERIMENTAL
Intervention: Longstanding active exercise therapy (52 weeks)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis
Number of subjects: 430
Study: 32687582

Group type: EXPERIMENTAL
Intervention: Machine learning model based on pretreatment symptoms and electroencephalographic features
Number of subjects: 0
Study: 35098177

Group type: EXPERIMENTAL
Intervention: ARCoV mRNA vaccine (5 µg, 10 µg, 15 µg, 20 µg, 25 µg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ARCoV mRNA vaccine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ARCoV mRNA vaccine (15 µg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33888418

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloons (PCB)
Number of subjects: 580

Group type: COMPARATOR
Intervention: Sirolimus-coated balloons (SCB)
Number of subjects: 580
Study: 33901759

Group type: EXPERIMENTAL
Intervention: iLookOut online child abuse identification and reporting training
Number of subjects: 1094

Group type: COMPARATOR
Intervention: Standard mandated reporter training
Number of subjects: 1094
Study: 34622504

Group type: EXPERIMENTAL
Intervention: 7-day vonoprazan-based triple therapy (7-VAC): vonoprazan 20 mg bid. pc., amoxicillin 1000 mg bid. pc., clarithromycin 500 mg bid. pc.
Number of subjects: 122

Group type: COMPARATOR
Intervention: 14-day omeprazole-based triple therapy (14-OAC): omeprazole 20 mg bid. ac., amoxicillin 1000 mg bid. pc., clarithromycin 500 mg bid. pc.
Number of subjects: 122
Study: 34866250

Group type: EXPERIMENTAL
Intervention: Short Implants (SI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard Length Implants (SLI) with MSFA
Number of subjects: 40
Study: 32173228

Group type: EXPERIMENTAL
Intervention: Health education intervention consisting of oral presentation and distribution of fliers for 30 minutes.
Number of subjects: 1259

Group type: COMPARATOR
Intervention: Control group received health talk on other aspects of neurology such as sleep, epilepsy, etc.
Number of subjects: 1259
Study: 36357459

Group type: EXPERIMENTAL
Intervention: Cold Face Test (CFT) intervention
Number of subjects: 28
Study: 32629994

Group type: EXPERIMENTAL
Intervention: Textured insoles of different heights
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Artificial arch
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (normal feet)
Number of subjects: 26
Study: 33992610

Group type: EXPERIMENTAL
Intervention: Low-sensitivity pregnancy test
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Multilevel pregnancy test
Number of subjects: 88
Study: 32379244

Group type: EXPERIMENTAL
Intervention: Strength Training (ST)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 30
Study: 34154321

Group type: EXPERIMENTAL
Intervention: Neridronate (25 mg i.m./month)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Neridronate
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: COMPARATOR
Intervention: Neridronate and Placebo
Number of subjects: 39
Study: 32406553

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 41
Study: 35733086

Group type: EXPERIMENTAL
Intervention: Lidocaine (4 ml of 2% lidocaine in the outer cuff)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Remifentanil (2 ng/ml maintained until extubation)
Number of subjects: 98
Study: 33302570

Group type: EXPERIMENTAL
Intervention: 25‐hydroxyvitamin D3 (25OHD) 10 µg per day for 16 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0